摘要
目的:评价我院抗肿瘤口服中成药的使用现状,促进合理用药。方法:对我院2008-2011年抗肿瘤口服中成药的销售金额、用药频度(DDDs)、日用药金额(DDC)、药物利用指数(DUI)进行排序和分析。结果:我院2008-2011年抗肿瘤口服中成药品种基本固定,销售金额呈逐年上升趋势,疗效确切、价格适中的中成药DDDs、DDC、DUI排序靠前。结论:我院抗肿瘤中成药的应用基本合理,在临床用药过程中要综合考虑疗效和经济两方面。
OBJECTIVE: To evaluate the status quo of the utilization of antineoplastic Chinese patent medicine in our hospital and to promote rational use of drugs. METHODS: The consumption sum, DDDs, DDC and DUI of antineoplastic Chinese patent medicine in our hospital during the period of 2008-2010 were analyzed statistically. RESULTS: The variety of antineoplastic Chinese patent medicine in our hospital was stable during 2008-2011, the consumption sum of drugs increased year by year, suitable price and effective therapeutic efficacy of Chinese patent medicine took the lead on the list of DDDs and DDC. CONCLUSION: In our hospital, the utilization of antineoplastic Chinese patent medicine is rational on the whole. Comprehensive considerations including good effect and reasonable cost should be taken into account during clinical drug use.
出处
《中国药房》
CAS
CSCD
2012年第23期2187-2189,共3页
China Pharmacy